Summary
Symplmed Inc (Symplmed) is a pharmaceutical company that focuses on streamlining the prescription process for boosting value of its medicines and those of its industry partners. The company offers patented technology platform, DyrctAxess to enables direct delivery of medications to patient’s home and eliminates the problem of unfilled prescriptions. Symplmed’s offers proprietary ACE inhibitor ACEON and Prestalia for high blood pressure. The company ensures that medicines required for managing a particular disease state are available through its patented DyrctAxess platform. The company serves pharmaceutical and healthcare sectors. Symplmed is headquartered in Cincinnati, Ohio, the US.
Symplmed Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Symplmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Symplmed Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Symplmed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Symplmed Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Symplmed Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Symplmed Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Symplmed Acquires US Rights for Aceon 10
Partnerships 11
Medpace Enters into Agreement with Symplmed Pharmaceuticals 11
Licensing Agreements 12
Symplmed Pharma Enters Into Licensing Agreement With Xoma For Perindopril Franchise 12
Acquisition 14
Medpace Investors Acquires Majority Stake in Symplmed Pharma 14
Symplmed Inc - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18
List of Tables
Symplmed Inc, Pharmaceuticals & Healthcare, Key Facts 1
Symplmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Symplmed Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Symplmed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Symplmed Inc, Deals By Therapy Area, 2010 to YTD 2016 8
Symplmed Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Symplmed Acquires US Rights for Aceon 10
Medpace Enters into Agreement with Symplmed Pharmaceuticals 11
Symplmed Pharma Enters Into Licensing Agreement With Xoma For Perindopril Franchise 12
Medpace Investors Acquires Majority Stake in Symplmed Pharma 14
Symplmed Inc, Key Competitors 15
Symplmed Inc, Key Employees 16
List of Figures
Symplmed Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Symplmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Symplmed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Symplmed Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Symplmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Symplmed Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Symplmed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Symplmed Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8